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Edited by Julian SchroederAbstract In this study, the human cytochrome P450 (CYP)
2A6 was used in order to modify the alkaloid production of to-
bacco plants. The cDNA for human CYP2A6 was placed under
the control of the constitutive 35S promoter and transferred into
Nicotiana tabacum via Agrobacterium-mediated transformation.
Transgenic plants showed formation of the recombinant
CYP2A6 enzyme but no obvious phenotypic changes. Unlike
wild-type tobacco, the transgenic plants accumulated cotinine,
a metabolite which is usually formed from nicotine in humans.
This result substantiates that metabolic engineering of the plant
secondary metabolism via mammalian P450 enzymes is possible
in vivo.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The cytochrome P450 monooxygenases (CYPs), heme-con-
taining mixed-function oxidases of highly divergent function,
constitute the largest family of plant enzymes. For Arabidopsis,
273 named genes have been listed [1] (http://www.p450.kvl.dk/
and http://arabidopsis-p450.biotec.uiuc.edu) and it is assumed
that a similar or even higher number could be found in other
plants [2,3]. Plant P450s have been reported to be involved
in diﬀerent physiological processes [4] with a limited numberAbbreviations: P450, cytochrome P450 monooxygenase; CaMV,
cauliﬂower mosaic virus; LC/MS, liquid chromatography/mass spec-
trometry
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doi:10.1016/j.febslet.2005.02.082of functional similar P450s involved in the formation of essen-
tial components needed by virtually all plants. Examples are
oxygenated fatty acids for cutin and suberin biosynthesis [5],
phytohormones like gibberellin [6], or signaling molecules like
oxylipins [7]. Another fraction of the plant P450s is involved in
the detoxiﬁcation of exogenous compounds like herbicides and
pollutants and this particular set of P450s might account for
the resistance to certain herbicides among plant species [2,8].
A third fraction of the P450s is responsible for essential steps
in the biosynthesis of the vast amount of plant secondary
metabolites [4]. Some of these metabolites could function as
UV-protectants which are present in all plant species but
others serve as defense compounds against bacterial, fungal,
insect, or animal predators [9].
With the increasing knowledge about the biosynthetic capac-
ity of P450s and availability of the encoding cDNA sequences,
attempts have been made to manipulate plant metabolism by
expressing foreign P450 genes. In several studies the tolerance
of plants to herbicides was modiﬁed by the introduction of
P450 genes from diﬀerent donor species. For example,
CYP71A10 from soybean enhanced the resistance against phe-
nylurea herbicides when it was introduced into the tobacco
genome [10]. CYP1A1 from rat mediated an enhanced chlor-
toluron resistance when introduced into the tobacco genome
[11,12], proving that recombinant mammalian P450s have
the potential to inﬂuence the metabolism of xenobiotics in
plants.
Also the modiﬁcation of biosynthetic pathways in plants is
an enormous challenge since an improved secondary metabo-
lism would increase the value of a crop or medicinal plant
[13–15]. There are numerous attempts to inﬂuence the forma-
tion of secondary compounds in plants by genetic engineering
with some employing the shuﬄing of P450s between diﬀerent
plant species. In this way, the phenylpropanoid pathway of
plants has been successfully changed by the expression of for-
eign P450 genes [16]. For example, the transformation of the
soybean 2-hydroxyisoﬂavanone synthase gene into Arabidopsis
resulted in the formation of genistein which is not a constituent
of the host plant [17]. However, with the narrow substrate
speciﬁcity of most plant P450s it is unlikely that novel com-
pounds could be formed by the heterologous enzymes.
In contrast to most plant P450 enzymes, some mamma-















Fig. 1. Metabolism of nicotine (1) to cotinine (3). Compound (1) is hydroxylated by CYP2A6 (a) to 5 0-hydroxynicotine. The conversion of the latter
to (3) is catalyzed by a putative aldehyde oxidase (b).
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families 1, 2, 3 that metabolize a huge variety of xenobiotics
including pharmaceuticals and plant metabolites ingested with
food [18]. Hence, it could be hypothesized that the expression
of human P450 genes could enable transgenic plants to accom-
plish novel biochemical reactions and to accumulate new sec-
ondary compounds [19]. A limited number of publications
report the expression of mammalian P450 genes in plants for
purposes other than enhanced herbicide metabolism. Doty
et al. showed that expression of drug metabolizing mammalian
CYP2E1 resulted in an enhanced metabolism of halogenated
hydrocarbons in tobacco [20] but changes in the alkaloid pat-
tern have not been reported so far. Saito et al. [21] transferred
rabbit CYP2C14 into tobacco and obtained plants which
accumulated 2-propenylpyrrolidine, a degradative metabolite
of nicotine. However, the occurrence of this compound was
not due to the transgene but rather an eﬀect of the enhanced
senescence of the transgenic plants caused by other, so far
not elucidated, eﬀects.
To determine if a human drug metabolizing P450 enzyme
could inﬂuence the pattern of secondary metabolites in plants,
we expressed the cDNA encoding human CYP2A6 in tobacco
plants which naturally accumulate the CYP2A6-speciﬁc sub-
strate nicotine. In contrast to other human drug metabolizing
P450s, the substrate speciﬁcity of CYP2A6 is limited to a rel-
atively small number of chemicals. The CYP2A6-mediated
hydroxylation of coumarin to 7-hydroxycoumarin (umbellifer-
one) and the C-oxidation of nicotine to trans-5 0-hydroxy-
nicotine are the most prominent examples [22]. In humans,
5 0-hydroxynicotine is oxidized to the primary nicotine metabo-
lite cotinine by aldehyde oxidase [23] (Fig. 1). Because trans-5 0-
hydroxynicotine and cotinine are not constituents of tobacco
plants, their formation in transgenic tobacco plants would
indicate the presence of active human CYP2A6 and prove that
the enzyme has the ability to modify secondary metabolism in
vivo.2. Materials and methods
2.1. Plasmid construction
The cDNA encoding human cytochrome P450 2A6 was ampliﬁed by
PCR to introduce an NcoI restriction site at the 5 0-end for subsequent
cloning into the plant expression vector pPS1 as a NcoI/XbaI fragment.
In the resulting plasmid pPS12A6, the full-length CYP2A6 cDNA was
placed between the tobacco etch virus (TEV) 5 0-nontranslated leader
which functions as a translational enhancer [24] and the 3 0-untrans-
lated sequences from the soybean vspB gene. The construct uses the
cauliﬂower mosaic virus (CaMV) 35S promoter to drive translation
and the nptII gene for kanamycin selection. The plasmid was cloned
and transformed into Escherichia coli TOP 10 (Invitrogen) by methods
described in [25] and was mobilized into Agrobacterium tumefaciens
LBA4404 by the freeze–thaw method [26].2.2. Plant material and transformation
Tobacco plants (Nicotiana tabacum cv. Petit Havana) were grown in
the greenhouse with cycles of 16 h light and 8 h darkness. Growth tem-
perature range was between 16 and 22 C with a relative humidity of
60–70%. Transformation was achieved by cocultivating leaf discs from
sterile grown plantlets with Agrobacterium strain LBA4404 harboring
the expression plasmid [27]. Shoots were regenerated from transformed
calli selected on medium containing 0.1 mg/ml kanamycin, subse-
quently rooted on MS medium and transplanted to soil.
2.3. Nucleic acid isolation and detection
DNA puriﬁcation was performed with the CTAB-method described
by Rogers et al. [28]. Detection of transgenic plants was achieved by
PCR using a primer pair ﬂanking the N-terminal 787 bp of the
CYP2A6 cDNA and plant genomic DNA as a template.
Total RNA from plant tissue was isolated with TRItidy reagent
(Applichem, Darmstadt, Germany) according to the manufacturers
protocol. RNA, 5 lg per lane, was loaded on a 1% denaturing gel.
Electrophoretic separation of RNA and transfer to a nylon membrane
was performed as described in standard protocols [25]. RNA bound to
the membrane was transiently stained with methylene blue solution
(0.25% methylene blue, 0.3% sodium acetate, pH 5.2). Speciﬁc detec-
tion of the target RNA was achieved with the non-radioactive nucleic
acid labelling and detection system (DIG, Roche Molecular Biochem-
icals, Mannheim, Germany). For PCR ampliﬁcation with the PCR
DIG probe synthesis kit (Roche) the two oligonucleotides described
above were used to generate a 787 bp digoxigenin-11-dUTP-labeled
DNA fragment.
2.4. Protein analysis
Total leaf protein was extracted directly in 2· SDS sample buﬀer
(100 mM Tris–HCl, pH 8; 200 mM dithiothreitol; 4% sodium dodecyl
sulfate (w/v); 0.2% bromophenol blue (w/v); and 20% glycerol (w/w)).
Frozen ground leaf (100 lg) was mixed with 200 ll of sample buﬀer
and boiled for 10 min. After centrifugation (14000 · g) samples were
separated on a 10% polyacrylamide gel and subsequently transferred
to a PVDF membrane, and the membrane was blocked overnight with
5% skim milk powder in phosphate-buﬀered saline with 0.05% Tween
20 (PBST). Blots were incubated with rabbit anti-human CYP2A6
(BioTrend, Ko¨ln, Germany) at a concentration of 1:2000 in PBST
for 2 h. After washing, 1 h incubation with goat anti rabbit IgG
HRP conjugated (1:20000 in PBST), and detection with Super Signal
chemiluminescent substrate (Pierce, Bonn, Germany) membranes were
exposed to X-ray ﬁlms.
2.5. Sample preparation and LC/MS analysis
Leaves of greenhouse-grown plants were harvested and immediately
frozen in liquid nitrogen. After freeze-drying, 0.15 g of the powdered
leaf material was extracted with 25% MeOH (v/v) for 30 min in an
ultrasonic bath at 40 C. After centrifugation (9000 · g for 10 min)
25 ll of the clear supernatant was injected onto a 250 · 4.6 mm,
5 lm analytical HPLC column (MetaChem Polaris C18-A; Varian,
Darmstadt, Germany). The mobile phase consisted of 10 mM ammo-
nium acetate/0.1% acetic acid (A) and MeOH (B). The ﬂow rate was
set to 0.8 ml/min and the following gradient (% B) was applied:
0 min: 20, 12.0 min: 65. After 12 min the column was ﬂushed with
100% (B) for 5 min and re-equilibrated with 20% (A) for 5 min. The
temperature for the analytical column was set to 25 C. An ion trap
mass spectrometer (Agilent, Waldbronn, Germany) consisting of
the following series 1100 HPLC components: G1379A vacuum degas-
ser, G1312A binary pump, G1313A autosampler, G1316A column
Fig. 3. Western blot analysis of CYP2A6 protein in plant extracts of
wild-type and transgenic tobacco plants. WT: untransformed tobacco;
M: marker lane; 3, 4, 7, 9, 13: transgenic lines.
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detection of cotinine using electrospray ionisation (ESI) in the positive
ion mode. Nitrogen was used for the nebuliser (50 psi) and the drying
gas (300 C, 12 l/min). The capillary voltage was 3500 V and the
skimmer, octopole 1, octopole 2 and capillary exit voltage were set
to 40, 12, 1.7 and 104 V, respectively.
The quantiﬁcation of cotinine in the tobacco plants was performed
using external calibration. For this purpose, we prepared ﬁve calibra-
tion solutions with cotinine concentrations of 500, 250, 100, 25, and
10 ng/ml in MeOH 25 % (v/v). Every calibration sample was injected
three times and the cotinine concentration was calculated after linear
regression analysis (y = 25332x + 133922; R2 = 0.9999). The limit of
detection and quantiﬁcation was 3 and 10 ng/ml, respectively.3. Results
We cloned the full-length cDNA of human CYP2A6 in the
plant transformation vector pPS1 under the control of the
CaMV 35S promoter. This construct should provide constitu-
tive expression in all parts of the tobacco plant and a high level
of the CYP2A6 transcript due to the presence of 5 0- and 3 0-reg-
ulatory elements (TEV leader and vsp-terminator, respectively).
After Agrobacterium-mediated transformation, independent
kanamycin-resistant plantlets were obtained. RNA-blot analy-
sis revealed that seven out of eleven plants exhibited CYP2A6
transcripts at diﬀerent levels, plants number 3, 7, and 13 having
the highest mRNA content (Fig. 2). Tobacco plants were
transferred into the greenhouse and grown under standard con-
ditions. No obvious changes could be observed in their pheno-
type. In contrast, Saito et al. [21] reported early senescence in
tobacco plants expressing a diﬀerent mammalian P450 gene
(rabbit CYP2C14).
In order to determine the expression level of the P450-trans-
gene, we tested plant protein extracts by immunoblot analysis
using a commercially available antiserum against human
CYP2A6. We were able to detect CYP2A6 protein in three
independent plant lines (lines 3, 7, and 13 (Fig. 3)) indicating
a clear correlation existed between the transcript abundance
and the detectable amount of P450 enzyme.
No protein crossreacting with the CYP2A6 antibody could
be detected in untransformed tobacco but all protein extracts
tested exhibited an additional signal derived from a protein
with a higher electrophoretic mobility and a molecular weight
of approximately 40 kDa. This observation suggested the non-
speciﬁc binding of the antiserum to an endogenous plant pro-Fig. 2. Analysis of the CYP2A6 transcript abundance in transgenic tobacc
hybridized with a CYP2A6-speciﬁc probe. (B) Methylene blue-stained total Rtein rather than to degradation products of the recombinant
CYP2A6 protein.
For the determination of cotinine in plant material, leaves
were harvested from greenhouse-grown plants, extracted, and
subjected to liquid chromatography/mass spectrometry (LC/
MS) analysis. In Fig. 4, the extracted ion chromatograms of
m/z 177 ([MH]+ of cotinine) are shown for extracts from the
wild-type plants and lines 4 and 7 (lines 3 and 13 were identical
to line 7 and are not shown in Fig. 4). Only the extracts from
lines 3, 7, and 13 showed a distinct signal at the retention time
of authentic cotinine suggesting that nicotine was oxidized to
5 0-hydroxynicotine by the recombinant CYP2A6 protein and
subsequently dehydrogenated to cotinine by an endogenous
dehydrogenase (Fig. 4C with structures in Fig. 1). Quantiﬁca-
tion of the cotinine content in lines 3, 7, and 13 with LC/MS
revealed cotinine concentrations between 2 and 7 ppm.
Whereas these cotinine concentrations are rather low, we could
not detect cotinine in lines 4, 9, and wild-type tobacco plants.
The correlation between mRNA abundance, CYP2A6 protein
accumulation and formation of the enzymatic product cotinine
is shown in Table 1. As can be clearly seen for the plant lines 3,
7, and 13, only high levels of speciﬁc mRNA led to the detect-
able accumulation of the CYP2A6 protein and the production
of cotinine (Table 1). No further changes in the metabolite pat-
tern of the transgenic tobacco plants were observed after addi-
tional LC/UV and LC/MS ﬁngerprint analysis (data not
shown). Since the cotinine content in the plant lines 3, 7, and
13 was comparably low and an additional dehydrogenation
is required for the formation of cotinine from nicotine (Fig.
1), we extracted additional signals of the total ion current in
order to identify further oxidized metabolites of nicotine or
cotinine. However, we obtained no additional signals in theo plants. (A) Northern blot of total RNA from diﬀerent plant lines
NA. WT: wild-type tobacco plants. 1–13: Independent transformants.
Fig. 4. LC/MS analysis of cotinine in wild-type and transgenic tobacco plants. The extracted ion electropherograms at m/z 177 correspond to the
protonated molecule (MH+ ion) of cotinine (Mr 176). (A) Wild-type tobacco. (B) Transgenic line 4 with low CYP2A6 transcript abundancy. (C)
Transgenic line 7 with high CYP2A6 transcript accumulation.
Table 1
Dependence of cotinine production on CYP2A6 transcript levels and
CYP2A6 protein accumulation in transgenic tobacco plants
Plant line WT 1 WT 2 3 4 9 7 13
RNA   +++ + + +++ +++
Protein   +   + +
Cotinine   +   + +
–: not detectable.
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oxygenated to 5 0-hydroxynicotine and subsequently dehydro-
genated to cotinine without accumulation of oxygenated
metabolites of nicotine or cotinine.
Because CYP2A6 was not present in the wild-type plants and
no CYP2A6 protein could be detected in line 4 we conclude that
in plant lines 3, 7, and 13 catalytically active CYP2A6 hydrox-
ylated nicotine to 5 0-hydroxynicotine, which was further
metabolized to cotinine by an endogenous plant enzyme.4. Discussion
In the present study, we demonstrated the heterologous
expression of the human CYP2A6 cDNA in tobacco plants.
Only modiﬁed plants with high expression levels of the trans-
gene produced catalytically active CYP2A6 which resulted in
the formation of cotinine, a metabolite usually not found in
tobacco.
The amount of the new metabolite cotinine is relatively low
and several reasons may account for this observation. P450 en-
zymes usually cooperate with a NADPH-P450 reductase as an
electron donor and it is remarkable that the mammalian
CYP2A6 is able to use a NADPH-P450 reductase from the
plant host as redox partner although there is a moderate se-
quence identity of oxidoreductases from mammals and plants
(e.g., 35% identity between human P450 reductase and Arabid-
opsis P450 reductase (ATR1)). However, ineﬃcient coupling of
this plant P450 reductases with the mammalian CYP2A6 could
account for the reduced activity of the recombinant CYP2A6
in this system [29].In humans, CYP2A6 is responsible for the 5 0-hydroxylation
of nicotine and a second enzymatic step catalyzed by an alde-
hyde oxidase is necessary to form cotinine (Fig. 1) [23]. Thus,
the low cotinine content in transgenic tobacco leaves could
also result from low levels of aldehyde oxidase, the second en-
zyme needed in cotinine formation. Since cotinine is found in
plants we speculate that an enzymatic activity comparable to
the human aldehyde oxidase must also be present in tobacco.
The absence of 5 0-hydroxynicotine leads to the conclusion
that it is quantitatively converted to cotinine. Therefore, the
limiting step in cotinine formation should be the 5 0-hydroxyl-
ation of nicotine rather than the dehydrogenation of
5 0-hydroxynicotine.
When analyzing the ﬁngerprint spectra of both transgenic
and wild-type tobacco extracts we noticed almost no changes
or diﬀerences in the metabolite pattern. This is not an unex-
pected ﬁnding since the P450 used in this study is an enzyme
which accepts and converts only a limited number of sub-
strates and would not aﬀect the majority of secondary metab-
olites found in tobacco. However, with the heterologous
expression of the human CYP2A6 gene we have proven that
the secondary metabolism of a plant can be selectively modi-
ﬁed to produce structures usually not found in plants. By
choosing genes whose encoded enzymes accept substrates
which are naturally present in the host plants, novel com-
pounds can be generated. Future experiments in which the
transferred P450 gene (e.g., CYP3A4 which exhibits a very
broad substrate acceptance) and the host plant are varied will
show whether appreciable amounts of various novel com-
pounds can be generated by the introduction of human P450
genes into plants.
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